Drugmaker Novo Nordisk's third-quarter operating profit slightly lags forecast

FILE PHOTO: The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the facade of a production plant in Chartres, north-central France, April 21, 2016. REUTERS/Guillaume Souvant/File Photo - Copyright POOL New(Reuters)

By Reuters

Published on 01/11/2019 - 09:34•Updated 07/05/2024 - 12:02

Comments

COPENHAGEN (Reuters) - Novo Nordisk <NOVOb.CO> posted third-quarter operating profit a touch below expectations on Friday but nudged up its sales outlook for this year on the back of its new drugs for type 2 diabetes and obesity.

The world's largest maker of diabetes drugs posted a quarterly operating profit of 12.9 billion Danish crowns ($1.93 billion), slightly below an average 13.1 billion crowns forecast in a Refinitiv poll of analysts.